source
- Electra Therapeutics raises $350 million in oversubscribed IPOElectra Therapeutics, a South San Francisco biotech focused on inflammation, completed its Nasdaq IPO, selling 23.3 million shares at $15 each and generating $350 million in gross proceeds. This a…
- Legend Biotech appoints former Novartis exec Ingrid Zhang as CEO amid falling share priceLegend Biotech announced the appointment of Ingrid Zhang, a former Novartis executive, as its new chief executive officer. The leadership change comes as the company faces growing competition for…